2024-06-12T10:51:10.580Z

103 Hummingbird

103 Hummingbird
Lung cancer

A Phase 1b Study to Evaluate HMBD-001 in Combination with Docetaxel with or without Cetuximab in Participants with Advanced Squamous Non-Small Cell Lung Cancers (HMBD-001-103 Hummingbird)

A Phase 1b Study to Evaluate HMBD-001 in Combination with Docetaxel with or without Cetuximab in Participants with Advanced Squamous Non-Small Cell Lung Cancers (HMBD-001-103 Hummingbird)

Trial overview

Clinical Area

Medical Oncology

Disease / Condition

Lung Cancer

Study Phase

1b

Trial registration

Number: NCT05910827

Further information
GenesisCare Location(s)

GenesisCare North Shore 

GenesisCare North Shore  :::
Principal Investigator(s)

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.